WallStreetZenWallStreetZen

NASDAQ: ACCD
Accolade Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ACCD

Based on 14 analysts offering 12 month price targets for Accolade Inc.
Min Forecast
$9.00-24.75%
Avg Forecast
$13.07+9.29%
Max Forecast
$16.00+33.78%

Should I buy or sell ACCD stock?

Based on 16 analysts offering ratings for Accolade Inc.
Buy
Strong Buy
6 analysts 37.5%
Buy
2 analysts 12.5%
Hold
8 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACCD stock forecasts and price targets.

ACCD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Jefferies
Bottom 27%
27
HoldDowngrades$14.00+17.06%2023-02-09
Raymond James
Bottom 27%
27
BuyInitiates Coverage On$15.00+25.42%2023-02-02
Truist Securities
Bottom 3%
3
Strong BuyMaintains$14.00+17.06%2023-01-30
Morgan Stanley
Top 3%
98
HoldMaintains$11.00-8.03%2023-01-06
Wells Fargo
Bottom 10%
10
HoldMaintains$10.00-16.39%2022-10-12
Goldman Sachs
Bottom 19%
19
Strong BuyMaintains$16.00+33.78%2022-10-07
Credit Suisse
Bottom 9%
9
HoldMaintains$11.00-8.03%2022-10-07
SVB Leerink
Bottom 3%
3
HoldMaintains$13.00+8.70%2022-10-07
Piper Sandler
Top 27%
74
Strong BuyMaintains$13.00+8.70%2022-10-04
Needham
Top 21%
80
BuyMaintains$15.00+25.42%2022-10-04

1 of 2

Forecast return on equity

Is ACCD forecast to generate an efficient return?
Company
-25.91%
Industry
10.82%
Market
52.42%
ACCD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACCD forecast to generate an efficient return on assets?
Company
-13.78%
Industry
8.68%
ACCD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACCD earnings per share forecast

What is ACCD's earnings per share in the next 2 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$2.06
Avg 2 year Forecast
-$1.73

ACCD revenue forecast

What is ACCD's revenue in the next 2 years based on estimates from 5 analysts?
Avg 1 year Forecast
$408.3M+14.1%
Avg 2 year Forecast
$485.3M+35.61%
ACCD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACCD revenue growth forecast

How is ACCD forecast to perform vs Health Information Services companies and vs the US market?
Company
16.45%
Industry
21.25%
Market
9.35%
ACCD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACCD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACCD vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
ACCD$11.96$13.07+9.29%Buy
SLP$42.64$65.00+52.44%Buy
HSTM$26.25$26.00-0.95%Hold
SHCR$2.13$3.15+47.89%Buy
HCAT$12.07$17.67+46.37%Buy
View Top Health Information Service Stocks

Accolade Stock Forecast FAQ

Is Accolade Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 16 Wall Street analysts covering (NASDAQ: ACCD) stock is to Buy ACCD stock.

Out of 16 analysts, 6 (37.5%) are recommending ACCD as a Strong Buy, 2 (12.5%) are recommending ACCD as a Buy, 8 (50%) are recommending ACCD as a Hold, 0 (0%) are recommending ACCD as a Sell, and 0 (0%) are recommending ACCD as a Strong Sell.

If you're new to stock investing, here's how to buy Accolade stock.

What is ACCD's earnings growth forecast for 2024-2025?

(NASDAQ: ACCD) Accolade's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 18.8%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 26.82%.

Accolade's earnings in 2023 is -$463,773,000.On average, 6 Wall Street analysts forecast ACCD's earnings for 2024 to be -$149,940,699, with the lowest ACCD earnings forecast at -$180,511,133, and the highest ACCD earnings forecast at -$111,363,723.

In 2025, ACCD is forecast to generate -$125,921,072 in earnings, with the lowest earnings forecast at -$156,491,506 and the highest earnings forecast at -$104,812,916.

What is ACCD's revenue growth forecast for 2024-2025?

(NASDAQ: ACCD) Accolade's forecast annual revenue growth rate of 16.45% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 21.25%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.35%.

Accolade's revenue in 2023 is $357,873,000.On average, 5 Wall Street analysts forecast ACCD's revenue for 2024 to be $29,721,740,270, with the lowest ACCD revenue forecast at $29,372,363,884, and the highest ACCD revenue forecast at $30,395,745,547.

In 2025, ACCD is forecast to generate $35,323,917,826 in revenue, with the lowest revenue forecast at $34,718,550,452 and the highest revenue forecast at $36,538,946,994.

What is ACCD's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: ACCD) forecast ROA is -13.78%, which is lower than the forecast US Health Information Services industry average of 8.68%.

What is ACCD's Price Target?

According to 14 Wall Street analysts that have issued a 1 year ACCD price target, the average ACCD price target is $13.07, with the highest ACCD stock price forecast at $16.00 and the lowest ACCD stock price forecast at $9.00.

On average, Wall Street analysts predict that Accolade's share price could reach $13.07 by Feb 9, 2024. The average Accolade stock price prediction forecasts a potential upside of 9.29% from the current ACCD share price of $11.96.

What is ACCD's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: ACCD) Accolade's current Earnings Per Share (EPS) is -$6.66. On average, analysts forecast that ACCD's EPS will be -$2.06 for 2024, with the lowest EPS forecast at -$2.48, and the highest EPS forecast at -$1.53. In 2025, ACCD's EPS is forecast to hit -$1.73 (min: -$2.15, max: -$1.44).

What is ACCD's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: ACCD) forecast ROE is -25.91%, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.